These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 34212484)
1. Response to the letter from Horowitz et al. to the Editor relating to the publication 'Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes' by Dahl et al. Dahl K; Baekdal TA Diabetes Obes Metab; 2021 Oct; 23(10):2414-2416. PubMed ID: 34212484 [No Abstract] [Full Text] [Related]
2. Response to Dahl et al.: Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes. Horowitz M; Rayner CK; Marathe CS; Wu T; Umapathysivam M; Jones KL Diabetes Obes Metab; 2021 Oct; 23(10):2411-2413. PubMed ID: 34169640 [No Abstract] [Full Text] [Related]
4. Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes. Dahl K; Brooks A; Almazedi F; Hoff ST; Boschini C; Baekdal TA Diabetes Obes Metab; 2021 Jul; 23(7):1594-1603. PubMed ID: 33710717 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus. Schirra J; Leicht P; Hildebrand P; Beglinger C; Arnold R; Göke B; Katschinski M J Endocrinol; 1998 Jan; 156(1):177-86. PubMed ID: 9496247 [TBL] [Abstract][Full Text] [Related]
6. Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial. Rayner CK; Watson LE; Phillips LK; Lange K; Bound MJ; Grivell J; Wu T; Jones KL; Horowitz M; Ferrannini E; Tricò D; Frascerra S; Mari A; Natali A Diabetes Care; 2020 Aug; 43(8):1813-1821. PubMed ID: 32471908 [TBL] [Abstract][Full Text] [Related]
7. Effects of the GLP-1 receptor agonist lixisenatide on postprandial glucose and gastric emptying--preclinical evidence. Werner U J Diabetes Complications; 2014; 28(1):110-4. PubMed ID: 23992745 [TBL] [Abstract][Full Text] [Related]
8. Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes. Jones KL; Rigda RS; Buttfield MDM; Hatzinikolas S; Pham HT; Marathe CS; Wu T; Lange K; Trahair LG; Rayner CK; Horowitz M Diabetes Obes Metab; 2019 May; 21(5):1158-1167. PubMed ID: 30623563 [TBL] [Abstract][Full Text] [Related]
9. A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 Diabetes. Wu T; Little TJ; Bound MJ; Borg M; Zhang X; Deacon CF; Horowitz M; Jones KL; Rayner CK Diabetes Care; 2016 Apr; 39(4):511-7. PubMed ID: 26786576 [TBL] [Abstract][Full Text] [Related]
10. Guar attenuates fall in postprandial blood pressure and slows gastric emptying of oral glucose in type 2 diabetes. Russo A; Stevens JE; Wilson T; Wells F; Tonkin A; Horowitz M; Jones KL Dig Dis Sci; 2003 Jul; 48(7):1221-9. PubMed ID: 12870776 [TBL] [Abstract][Full Text] [Related]
11. Gastric emptying and postprandial glucose excursions in adolescents with type 1 diabetes. Heptulla RA; Rodriguez LM; Mason KJ; Haymond MW Pediatr Diabetes; 2008 Dec; 9(6):561-6. PubMed ID: 18761650 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes. Cervera A; Wajcberg E; Sriwijitkamol A; Fernandez M; Zuo P; Triplitt C; Musi N; DeFronzo RA; Cersosimo E Am J Physiol Endocrinol Metab; 2008 May; 294(5):E846-52. PubMed ID: 18334612 [TBL] [Abstract][Full Text] [Related]
13. Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1. Sonne DP; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK Eur J Endocrinol; 2014 Oct; 171(4):407-19. PubMed ID: 24986531 [TBL] [Abstract][Full Text] [Related]
14. The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients. Flint A; Kapitza C; Hindsberger C; Zdravkovic M Adv Ther; 2011 Mar; 28(3):213-26. PubMed ID: 21340616 [TBL] [Abstract][Full Text] [Related]
15. The impact of soluble dietary fibre on gastric emptying, postprandial blood glucose and insulin in patients with type 2 diabetes. Yu K; Ke MY; Li WH; Zhang SQ; Fang XC Asia Pac J Clin Nutr; 2014; 23(2):210-8. PubMed ID: 24901089 [TBL] [Abstract][Full Text] [Related]
16. Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes. Meier JJ; Gallwitz B; Salmen S; Goetze O; Holst JJ; Schmidt WE; Nauck MA J Clin Endocrinol Metab; 2003 Jun; 88(6):2719-25. PubMed ID: 12788879 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Frank JW; Saslow SB; Camilleri M; Thomforde GM; Dinneen S; Rizza RA Gastroenterology; 1995 Sep; 109(3):755-65. PubMed ID: 7657103 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of gastric emptying. Young A Adv Pharmacol; 2005; 52():99-121. PubMed ID: 16492543 [TBL] [Abstract][Full Text] [Related]
19. Rate of gastric emptying is a determinant of postprandial hypotension in non-insulin-dependent diabetes mellitus. Jones KL; Tonkin A; Horowitz M; Wishart JM; Carney BI; Guha S; Green L Clin Sci (Lond); 1998 Jan; 94(1):65-70. PubMed ID: 9505868 [TBL] [Abstract][Full Text] [Related]
20. Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients. Gonlachanvit S; Hsu CW; Boden GH; Knight LC; Maurer AH; Fisher RS; Parkman HP Dig Dis Sci; 2003 Mar; 48(3):488-97. PubMed ID: 12757160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]